Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo
- PMID: 16539672
- DOI: 10.1111/j.1471-4159.2006.03741.x
Evidence that GAD65 mediates increased GABA synthesis during intense neuronal activity in vivo
Abstract
In this study we tested the hypothesis that the 65-kDa isoform of glutamate decarboxylase (GAD(65)) mediates activity-dependent GABA synthesis as invoked by seizures in anesthetized rats. GABA synthesis was measured following acute GABA-transaminase inhibition by gabaculine using spatially localized (1)H NMR spectroscopy before and after bicuculline-induced seizures. Experiments were conducted with animals pre-treated with vigabatrin 24 h earlier in order to reduce GAD(67) protein and also with non-treated controls. GAD isoform content was quantified by immunoblotting. GABA was higher in vigabatrin-treated rats compared to non-treated controls. In vigabatrin-treated animals, GABA synthesis was 28% lower compared to controls [p < 0.05; vigabatrin-treated, 0.043 +/- 0.011 micromol/(g min); non-treated, 0.060 +/- 0.014 micromol/(g min)] and GAD(67) was 60% lower. No difference between groups was observed for GAD(65). Seizures increased GABA synthesis in both control [174%; control, 0.060 +/- 0.014 micromol/(g min) vs. seizures, 0.105 +/- 0.043 micromol/(g min)] and vigabatrin-treated rats [214%; control, 0.043 +/- 0.011 micromol/(g min); seizures, 0.092 +/- 0.018 micromol/(g min)]. GAD(67) could account for at least half of basal GABA synthesis but only 20% of the two-fold increase observed in vigabatrin-treated rats during seizures. The seizure-induced activation of GAD(65) in control cortex occurs concomitantly with a 2.3-fold increase in inorganic phosphate, known to be a potent activator of apoGAD(65)in vitro. Our results are consistent with a major role for GAD(65) in activity-dependent GABA synthesis.
Similar articles
-
Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein.Brain Res. 2001 Sep 28;914(1-2):81-91. doi: 10.1016/s0006-8993(01)02778-0. Brain Res. 2001. PMID: 11578600
-
Acute regulation of steady-state GABA levels following GABA-transaminase inhibition in rat cerebral cortex.Neurochem Int. 2006 May-Jun;48(6-7):508-14. doi: 10.1016/j.neuint.2005.12.024. Epub 2006 Mar 3. Neurochem Int. 2006. PMID: 16517019
-
The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).Neurochem Res. 1996 Sep;21(9):1031-41. doi: 10.1007/BF02532413. Neurochem Res. 1996. PMID: 8897466
-
Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.Mol Neurobiol. 1998 Feb;16(1):97-121. doi: 10.1007/BF02740605. Mol Neurobiol. 1998. PMID: 9554704 Review.
-
Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.Epilepsia. 1994;35 Suppl 5:S29-32. doi: 10.1111/j.1528-1157.1994.tb05963.x. Epilepsia. 1994. PMID: 8039467 Review.
Cited by
-
Altered Parvalbumin Basket Cell Terminals in the Cortical Visuospatial Working Memory Network in Schizophrenia.Biol Psychiatry. 2021 Jul 1;90(1):47-57. doi: 10.1016/j.biopsych.2021.02.009. Epub 2021 Feb 19. Biol Psychiatry. 2021. PMID: 33892915 Free PMC article.
-
Are anti-glutamic acid decarboxylase 65-kDa isoform antibodies related to diabetes or brain tumor?Eur J Med Res. 2022 Apr 6;27(1):53. doi: 10.1186/s40001-022-00674-3. Eur J Med Res. 2022. PMID: 35387690 Free PMC article.
-
GAD65 Promoter Polymorphism rs2236418 Modulates Harm Avoidance in Women via Inhibition/Excitation Balance in the Rostral ACC.J Neurosci. 2018 May 30;38(22):5067-5077. doi: 10.1523/JNEUROSCI.1985-17.2018. Epub 2018 May 3. J Neurosci. 2018. PMID: 29724796 Free PMC article.
-
Histone deacetylase as emerging pharmacological therapeutic target for neuropathic pain: From epigenetic to selective drugs.CNS Neurosci Ther. 2024 May;30(5):e14745. doi: 10.1111/cns.14745. CNS Neurosci Ther. 2024. PMID: 38715326 Free PMC article. Review.
-
Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.Neurotox Res. 2008 Oct;14(2-3):237-48. doi: 10.1007/BF03033813. Neurotox Res. 2008. PMID: 19073429 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical